2025-01-012025-12-312025-12-31false07102415MAYORMEDICAL CONSULTING LIMITED2026-08-24falseiso4217:GBPxbrli:pure071024152024-12-31071024152025-12-31071024152025-01-012025-12-31071024152023-12-31071024152024-12-31071024152024-01-012024-12-3107102415bus:SmallEntities2025-01-012025-12-3107102415bus:AuditExempt-NoAccountantsReport2025-01-012025-12-3107102415bus:FullAccounts2025-01-012025-12-3107102415bus:PrivateLimitedCompanyLtd2025-01-012025-12-3107102415core:WithinOneYear2025-12-3107102415core:AfterOneYear2025-12-3107102415core:WithinOneYear2024-12-3107102415core:AfterOneYear2024-12-3107102415core:ShareCapital2025-12-3107102415core:SharePremium2025-12-3107102415core:RevaluationReserve2025-12-3107102415core:OtherReservesSubtotal2025-12-3107102415core:RetainedEarningsAccumulatedLosses2025-12-3107102415core:ShareCapital2024-12-3107102415core:SharePremium2024-12-3107102415core:RevaluationReserve2024-12-3107102415core:OtherReservesSubtotal2024-12-3107102415core:RetainedEarningsAccumulatedLosses2024-12-3107102415core:LandBuildings2025-12-3107102415core:PlantMachinery2025-12-3107102415core:Vehicles2025-12-3107102415core:FurnitureFittings2025-12-3107102415core:OfficeEquipment2025-12-3107102415core:NetGoodwill2025-12-3107102415core:IntangibleAssetsOtherThanGoodwill2025-12-3107102415core:ListedExchangeTraded2025-12-3107102415core:UnlistedNon-exchangeTraded2025-12-3107102415core:LandBuildings2024-12-3107102415core:PlantMachinery2024-12-3107102415core:Vehicles2024-12-3107102415core:FurnitureFittings2024-12-3107102415core:OfficeEquipment2024-12-3107102415core:NetGoodwill2024-12-3107102415core:IntangibleAssetsOtherThanGoodwill2024-12-3107102415core:ListedExchangeTraded2024-12-3107102415core:UnlistedNon-exchangeTraded2024-12-3107102415core:LandBuildings2025-01-012025-12-3107102415core:PlantMachinery2025-01-012025-12-3107102415core:Vehicles2025-01-012025-12-3107102415core:FurnitureFittings2025-01-012025-12-3107102415core:OfficeEquipment2025-01-012025-12-3107102415core:NetGoodwill2025-01-012025-12-3107102415core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3107102415core:ListedExchangeTraded2025-01-012025-12-3107102415core:UnlistedNon-exchangeTraded2025-01-012025-12-3107102415core:MoreThanFiveYears2025-01-012025-12-3107102415core:Non-currentFinancialInstruments2025-12-3107102415core:Non-currentFinancialInstruments2024-12-3107102415dpl:CostSales2025-01-012025-12-3107102415dpl:DistributionCosts2025-01-012025-12-3107102415core:LandBuildings2025-01-012025-12-3107102415core:PlantMachinery2025-01-012025-12-3107102415core:Vehicles2025-01-012025-12-3107102415core:FurnitureFittings2025-01-012025-12-3107102415core:OfficeEquipment2025-01-012025-12-3107102415dpl:AdministrativeExpenses2025-01-012025-12-3107102415core:NetGoodwill2025-01-012025-12-3107102415core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3107102415dpl:GroupUndertakings2025-01-012025-12-3107102415dpl:ParticipatingInterests2025-01-012025-12-3107102415dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012025-12-3107102415core:ListedExchangeTraded2025-01-012025-12-3107102415dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012025-12-3107102415core:UnlistedNon-exchangeTraded2025-01-012025-12-3107102415dpl:CostSales2024-01-012024-12-3107102415dpl:DistributionCosts2024-01-012024-12-3107102415core:LandBuildings2024-01-012024-12-3107102415core:PlantMachinery2024-01-012024-12-3107102415core:Vehicles2024-01-012024-12-3107102415core:FurnitureFittings2024-01-012024-12-3107102415core:OfficeEquipment2024-01-012024-12-3107102415dpl:AdministrativeExpenses2024-01-012024-12-3107102415core:NetGoodwill2024-01-012024-12-3107102415core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3107102415dpl:GroupUndertakings2024-01-012024-12-3107102415dpl:ParticipatingInterests2024-01-012024-12-3107102415dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3107102415core:ListedExchangeTraded2024-01-012024-12-3107102415dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3107102415core:UnlistedNon-exchangeTraded2024-01-012024-12-3107102415core:NetGoodwill2025-12-3107102415core:IntangibleAssetsOtherThanGoodwill2025-12-3107102415core:LandBuildings2025-12-3107102415core:PlantMachinery2025-12-3107102415core:Vehicles2025-12-3107102415core:FurnitureFittings2025-12-3107102415core:OfficeEquipment2025-12-3107102415core:AfterOneYear2025-12-3107102415core:WithinOneYear2025-12-3107102415core:ListedExchangeTraded2025-12-3107102415core:UnlistedNon-exchangeTraded2025-12-3107102415core:ShareCapital2025-12-3107102415core:SharePremium2025-12-3107102415core:RevaluationReserve2025-12-3107102415core:OtherReservesSubtotal2025-12-3107102415core:RetainedEarningsAccumulatedLosses2025-12-3107102415core:NetGoodwill2024-12-3107102415core:IntangibleAssetsOtherThanGoodwill2024-12-3107102415core:LandBuildings2024-12-3107102415core:PlantMachinery2024-12-3107102415core:Vehicles2024-12-3107102415core:FurnitureFittings2024-12-3107102415core:OfficeEquipment2024-12-3107102415core:AfterOneYear2024-12-3107102415core:WithinOneYear2024-12-3107102415core:ListedExchangeTraded2024-12-3107102415core:UnlistedNon-exchangeTraded2024-12-3107102415core:ShareCapital2024-12-3107102415core:SharePremium2024-12-3107102415core:RevaluationReserve2024-12-3107102415core:OtherReservesSubtotal2024-12-3107102415core:RetainedEarningsAccumulatedLosses2024-12-3107102415core:NetGoodwill2023-12-3107102415core:IntangibleAssetsOtherThanGoodwill2023-12-3107102415core:LandBuildings2023-12-3107102415core:PlantMachinery2023-12-3107102415core:Vehicles2023-12-3107102415core:FurnitureFittings2023-12-3107102415core:OfficeEquipment2023-12-3107102415core:AfterOneYear2023-12-3107102415core:WithinOneYear2023-12-3107102415core:ListedExchangeTraded2023-12-3107102415core:UnlistedNon-exchangeTraded2023-12-3107102415core:ShareCapital2023-12-3107102415core:SharePremium2023-12-3107102415core:RevaluationReserve2023-12-3107102415core:OtherReservesSubtotal2023-12-3107102415core:RetainedEarningsAccumulatedLosses2023-12-3107102415core:AfterOneYear2025-01-012025-12-3107102415core:WithinOneYear2025-01-012025-12-3107102415core:Non-currentFinancialInstrumentscore:CostValuation2025-01-012025-12-3107102415core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-012025-12-3107102415core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-012025-12-3107102415core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-012025-12-3107102415core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-012025-12-3107102415core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-012025-12-3107102415core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3107102415core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3107102415core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3107102415core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3107102415core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3107102415core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3107102415core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3107102415core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3107102415core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3107102415core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3107102415core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3107102415core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3107102415core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3107102415core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3107102415core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3107102415core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3107102415core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3107102415core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3107102415core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3107102415core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3107102415core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3107102415bus:Director12025-01-012025-12-3107102415bus:Director22025-01-012025-12-31

MAYORMEDICAL CONSULTING LIMITED

Registered Number
07102415
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

MAYORMEDICAL CONSULTING LIMITED
Company Information
for the year from 1 January 2025 to 31 December 2025

Directors

MAYOR, Raka
MAYOR, Sunil Kumar, Dr

Registered Address

Ramsay Brown Llp 915
High Road
North Finchley
N12 8QJ

Registered Number

07102415 (England and Wales)
MAYORMEDICAL CONSULTING LIMITED
Statement of Financial Position
31 December 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets31,000,0001,000,000
Tangible assets419,37825,990
1,019,3781,025,990
Current assets
Debtors53,256,3523,295,799
Cash at bank and on hand4,3575,208
3,260,7093,301,007
Creditors amounts falling due within one year6(50,480)(77,737)
Net current assets (liabilities)3,210,2293,223,270
Total assets less current liabilities4,229,6074,249,260
Net assets4,229,6074,249,260
Capital and reserves
Called up share capital22
Profit and loss account4,229,6054,249,258
Shareholders' funds4,229,6074,249,260
The financial statements were approved and authorised for issue by the Board of Directors on 24 August 2026, and are signed on its behalf by:
MAYOR, Raka
Director
Registered Company No. 07102415
MAYORMEDICAL CONSULTING LIMITED
Notes to the Financial Statements
for the year ended 31 December 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Intangible assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Goodwill
Goodwill, being the amount paid in connection with the acquisition of business in 2020, is being amortised evenly over its estimated useful life of nil years.
Tangible fixed assets and depreciation
Property, plant and equipment is stated at cost less accumulated depreciation and impairment losses. Part of an item of property, plant and equipment having different useful lives are accounted for as separate items. Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives, using the straight line method. The estimated useful lives, residual values and depreciation method are reviewed at the end of each reporting period, with the effect of any changes in estimate accounted for on a prospective basis. Depreciation is provided to write off the cost less estimated residual value, of each asset over its expected useful life as follows:

Reducing balance (%)Straight line (years)
Plant and machinery25-
Vehicles25-
Office Equipment-4
2.Average number of employees

20252024
Average number of employees during the year00
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 January 251,000,0001,000,000
At 31 December 251,000,0001,000,000
Net book value
At 31 December 251,000,0001,000,000
At 31 December 241,000,0001,000,000
4.Tangible fixed assets

Plant & machinery

Vehicles

Office Equipment

Total

££££
Cost or valuation
At 01 January 257,01475,7443,05985,817
At 31 December 257,01475,7443,05985,817
Depreciation and impairment
At 01 January 255,14351,7782,90659,827
Charge for year4685,9911536,612
At 31 December 255,61157,7693,05966,439
Net book value
At 31 December 251,40317,975-19,378
At 31 December 241,87123,96615325,990
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables356,111425,314
Other debtors2,900,2412,870,485
Total3,256,3523,295,799
6.Creditors: amounts due within one year

2025

2024

££
Taxation and social security-36,793
Other creditors48,18937,757
Accrued liabilities and deferred income2,2913,187
Total50,48077,737
7.Creditors: amounts due after one year
8.Directors advances, credits and guarantees
As at the year end, the company owed the directors £38,189 (2024: £13,730).
9.Related party transactions
Included in other debtors due within one year is an amount of £2,889,765 (2024: £2,840,686) owed by Mayormedical LLP. Mayormedical LLP and the Company are connected by virtue of their common members and directors.